VANCOUVER, July 13, 2020 /CNW/ - H-Source Holdings Ltd.
(TSXV: HSI) (OTCQB: HSCHF) (the "Company" or
"H-Source") is pleased to announce it has entered into a
Letter of Intent ("LOI") with Relevium Technologies
("Relevium"), a corporation strategically focused on the
acquisition and distribution of products and technologies with
health and wellness in mind, to partner in the development,
strategic sourcing and supply of global Personal Protective
Equipment ("PPE") requirements due to COVID-19.
The HSource1 proprietary platform is focused on supplying the
significant demand for PPE products by providing a central location
for hospitals, governments, and businesses to procure highly needed
medical surgical supplies, pharmaceuticals, capital equipment and
wellness products. Relevium has established contracts with
multiple vendors and products that are approved for global
distribution, greatly increasing opportunities for supporting a
healthier world.
H-Source and Relevium have been in discussion for several months
about partnering to make the CleanCare line available through
HSource1, as well as other PPE products. HSource1 is a fully
secured and auditable platform that connects buyers and suppliers
in a secured, compliant, and transparent manner. The platform is
registered and approved in 35 states in the USA, as well as Canada and Europe. H-Source
partners with EY (formerly Ernst & Young) to deploy the
platform.
Strategic Partnership
H-Source and Relevium will be cooperating to list the Company's
product offerings and incorporating its newly developed network of
PPE products, vendors and buyers onto the H-Source1 platform.
Relevium's new business, Bioganix CleanCare is now poised to expand
to global markets utilizing the efficiencies of HSource1.
Both companies have expressed their intention, in the LOI, to
exchange equity and share resources to solidify the
partnership.
Aurelio Useche, CEO of Relevium
Technologies stated: "We are extremely pleased to partner with John
and his team to develop and master the global supply chain of
personal protection products not only during this pandemic, but
also to service the New Economic standard of supplying services to
consumers. We look forward to a mutually rewarding and profitable
cooperation"
John Kupice, CEO of H-Source
stated "We are excited to partner with Aurelio and Relevium, adding
Bioganix and their other innovative products to the HSource1
Global Virtual Purchasing Organization Platform. Jointly we will
service current PPE needs as well as enable new efficient
post COVID-19 supply chain processes and distribution
models."
About H-Source Holdings Ltd.
H-Source Holdings
Ltd. is a technology company operating within the healthcare
industry through its wholly owned subsidiary, H-Source, Inc. The
Company has developed a proprietary technology solution that
provides a private, secure and Software As A Service ("SAAS")
platform for members to buy, sell, track, and transfer medical
supplies, pharmaceuticals, capital equipment and products.
Integrated Artificial Intelligence ("AI") and Business Intelligence
("BI") enhance the data analytics for supply chain optimization.
The platform is FDA and DSCSA compliant for pharmaceuticals
including serialization, ownership and custody in extended modules.
Complete Blockchain integration is offered, as an add-on, for
additional security and traceability. The platform is
designed to increase supply chain efficiency and reduce costs,
moving products directly from OEMs on a B2B and / or B2C model.
For more information,
please visit http://h-source.com/.
About Relevium Technologies
Relevium is a publicly
traded Company that operates in the health and wellness industry,
including legal cannabis, with a primary focus on online
distribution. The principal business of the Company is the
identification, evaluation, acquisition and operation of brands and
businesses in the health and wellness markets and medical cannabis.
The Company pursues its business strategy through an acquisition
and partnership model in a holistic approach to encompass a wide
range of health and wellness consumer products. Relevium operates
through two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando, Florida, markets dietary supplements,
nutraceuticals, sports nutrition, and cosmeceuticals primarily
through its Bioganix® brand portfolio in the US and Europe.
Relevium's premium brands are sold at some of the world's
largest retailers including Walmart.com and Amazon.com.
On behalf of the board of directors of H-Source Holdings
Ltd.
John Kupice
CEO & Director
CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not
reviewed and does not accept responsibility for the adequacy or
accuracy of the content of this news release.
This news release contains forward-looking statements
relating to the completion of the listing of the Company's shares
on the TSXV and other statements that are not historical facts.
Forward-looking statements are often identified by terms such as
"will", "may", "should", "anticipate", "expects" and similar
expressions. All statements other than statements of historical
fact, included in this release are forward-looking statements that
involve risks and uncertainties. There can be no assurance that
such statements will prove to be accurate and actual results and
future events could differ materially from those anticipated in
such statements. Important factors that could cause actual results
to differ materially from the Company's expectations include the
failure to satisfy the conditions of the TSXV and other risks
detailed from time to time in the filings made by the Company with
securities regulations.
The reader is cautioned that assumptions used in the
preparation of any forward-looking information may prove to be
incorrect. Events or circumstances may cause actual results to
differ materially from those predicted, as a result of numerous
known and unknown risks, uncertainties, and other factors, many of
which are beyond the control of the Company. The reader is
cautioned not to place undue reliance on any forward-looking
information. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement. The
forward-looking statements contained in this news release are made
as of the date of this news release and the Company will update or
revise publicly any of the included forward-looking statements as
expressly required by applicable law.
SOURCE H-Source Holdings Ltd.
